S&P 500   4,278.24 (+0.10%)
DOW   33,899.70 (-0.24%)
QQQ   329.61 (+0.34%)
AAPL   174.40 (-0.09%)
MSFT   291.01 (-0.11%)
META   175.14 (+0.17%)
GOOGL   120.26 (+0.59%)
AMZN   142.35 (+0.18%)
TSLA   913.73 (+0.19%)
NVDA   187.69 (+2.37%)
NIO   19.87 (-1.05%)
BABA   90.79 (+1.14%)
AMD   100.66 (+2.43%)
MU   63.10 (+2.40%)
T   18.50 (+0.43%)
CGC   3.78 (-6.90%)
F   16.05 (+0.12%)
GE   79.30 (-0.78%)
DIS   122.51 (-0.24%)
AMC   19.83 (-7.16%)
PYPL   99.02 (-0.40%)
PFE   48.45 (-1.66%)
NFLX   244.94 (+1.57%)
S&P 500   4,278.24 (+0.10%)
DOW   33,899.70 (-0.24%)
QQQ   329.61 (+0.34%)
AAPL   174.40 (-0.09%)
MSFT   291.01 (-0.11%)
META   175.14 (+0.17%)
GOOGL   120.26 (+0.59%)
AMZN   142.35 (+0.18%)
TSLA   913.73 (+0.19%)
NVDA   187.69 (+2.37%)
NIO   19.87 (-1.05%)
BABA   90.79 (+1.14%)
AMD   100.66 (+2.43%)
MU   63.10 (+2.40%)
T   18.50 (+0.43%)
CGC   3.78 (-6.90%)
F   16.05 (+0.12%)
GE   79.30 (-0.78%)
DIS   122.51 (-0.24%)
AMC   19.83 (-7.16%)
PYPL   99.02 (-0.40%)
PFE   48.45 (-1.66%)
NFLX   244.94 (+1.57%)
S&P 500   4,278.24 (+0.10%)
DOW   33,899.70 (-0.24%)
QQQ   329.61 (+0.34%)
AAPL   174.40 (-0.09%)
MSFT   291.01 (-0.11%)
META   175.14 (+0.17%)
GOOGL   120.26 (+0.59%)
AMZN   142.35 (+0.18%)
TSLA   913.73 (+0.19%)
NVDA   187.69 (+2.37%)
NIO   19.87 (-1.05%)
BABA   90.79 (+1.14%)
AMD   100.66 (+2.43%)
MU   63.10 (+2.40%)
T   18.50 (+0.43%)
CGC   3.78 (-6.90%)
F   16.05 (+0.12%)
GE   79.30 (-0.78%)
DIS   122.51 (-0.24%)
AMC   19.83 (-7.16%)
PYPL   99.02 (-0.40%)
PFE   48.45 (-1.66%)
NFLX   244.94 (+1.57%)
S&P 500   4,278.24 (+0.10%)
DOW   33,899.70 (-0.24%)
QQQ   329.61 (+0.34%)
AAPL   174.40 (-0.09%)
MSFT   291.01 (-0.11%)
META   175.14 (+0.17%)
GOOGL   120.26 (+0.59%)
AMZN   142.35 (+0.18%)
TSLA   913.73 (+0.19%)
NVDA   187.69 (+2.37%)
NIO   19.87 (-1.05%)
BABA   90.79 (+1.14%)
AMD   100.66 (+2.43%)
MU   63.10 (+2.40%)
T   18.50 (+0.43%)
CGC   3.78 (-6.90%)
F   16.05 (+0.12%)
GE   79.30 (-0.78%)
DIS   122.51 (-0.24%)
AMC   19.83 (-7.16%)
PYPL   99.02 (-0.40%)
PFE   48.45 (-1.66%)
NFLX   244.94 (+1.57%)
OTCMKTS:GNFTF

Genfit - GNFTF Stock Forecast, Price & News

$3.87
0.00 (0.00%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$3.87
$3.87
50-Day Range
$3.87
$5.00
52-Week Range
$3.87
$3.87
Volume
N/A
Average Volume
329 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GNFTF stock logo

About Genfit (OTCMKTS:GNFTF) Stock

Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.

Receive GNFTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genfit and its competitors with MarketBeat's FREE daily newsletter.

GNFTF Stock News Headlines

Hedge Funds Are Betting On Genfit SA (GNFT)
GENFIT: 2021 Financial Calendar
GNFTF Real-Time Quotes
Genfit SA (XUP.SG)
GENFIT S.A. EO -,25 (XUP.MU)
Genfit SA to Host Earnings Call
Genfit up 47% on NASH test deal with LabCorp
Genfit bails on elafibranor in NASH
Intercept Shares Tumble on NASH Disappointment
Here's Why Shares of Durect Jumped Higher Today
See More Headlines
Receive GNFTF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genfit and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:GNFTF
CIK
N/A
Fax
N/A
Employees
122
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Jean-Francois Mouney (Age 67)
    Co-Founder & Chairman
    Comp: $338.96k
  • Mr. M. Pascal Prigent (Age 54)
    Chief Exec. Officer
    Comp: $513.66k
  • Prof. Bart Staels (Age 59)
    Co-Founder & Chairman of the Scientific Advisory Board
  • Mr. Thomas Baetz (Age 48)
    Chief Financial Officer
  • Mr. Pascal Caisey (Age 54)
    Chief Operating Officer
  • Dr. Dean W. Hum Ph.D. (Age 60)
    Chief Scientific Officer
  • Mr. Laurent Lannoo (Age 52)
    Corp. Sec. & Director of Legal Affairs
  • Ms. Stefanie Magner (Age 41)
    Chief Compliance Officer & VP of International Legal Affairs
  • Ms. Emilie Desodt (Age 39)
    Vice-Pres of HR
  • Mr. Jean-Christophe Marcoux (Age 45)
    Chief Strategy Officer













GNFTF Stock - Frequently Asked Questions

How have GNFTF shares performed in 2022?

Genfit's stock was trading at $5.00 at the start of the year. Since then, GNFTF shares have decreased by 22.6% and is now trading at $3.87.
View the best growth stocks for 2022 here
.

Are investors shorting Genfit?

Genfit saw a decline in short interest during the month of July. As of July 15th, there was short interest totaling 500 shares, a decline of 83.9% from the June 30th total of 3,100 shares. Based on an average trading volume of 0 shares, the short-interest ratio is presently ∞ days.
View Genfit's Short Interest
.

What is Genfit's stock symbol?

Genfit trades on the OTCMKTS under the ticker symbol "GNFTF."

How do I buy shares of Genfit?

Shares of GNFTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Genfit's stock price today?

One share of GNFTF stock can currently be purchased for approximately $3.87.

How many employees does Genfit have?

The company employs 122 workers across the globe.

How can I contact Genfit?

Genfit's mailing address is Parc Eurasante, Loos, Hauts-de-France 59120. The official website for the company is www.genfit.com. The company can be reached via phone at (332) 016-4000.

This page (OTCMKTS:GNFTF) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.